European Vaccine Initiative (EVI) and the Tuberculosis Vaccine Initiative (TBVI) are proud to announce a new partnership with Vaccine monitoring Collaboration for Europe (VAC4EU).
October 2024
VAC4EU is a pan-European research network for post-authorisation vaccine safety and benefit monitoring, specialised in the collaborative generation of real-world evidence on coverage, safety, and efficacy of vaccines in Europe.
EVI and TBVI are both European non-profit Product Development Partnerships (PDPs) that support global efforts to develop effective and affordable vaccines. While EVI is focused on the prevention of diseases of poverty and emerging infectious diseases, TBVI is focused on tuberculosis.
We are very interested in exchanging research and funding opportunities, collaborative fundraising efforts, networking, joint communication, and knowledge sharing with these two initiatives. We are exploring possible opportunities to co-create and collaborate on studies and topics of mutual interest (for example, European pandemic preparedness).
We are glad to take this initial step of signing a Memorandum of Understanding and look forward to working with VAC4EU and TBVI!
Comments